Funds Holding Endologix, Inc.

 
Funds Holding Endologix, Inc. top ^
  • Holdings: Endologix, Inc., Biomarin Pharmaceutical, Inc., Team Health Holdings Inc, Triumph Group, Inc., Signature Bank
  • Category: Small Growth
  • Morningstar Rating: 1 Stars
Sign-up for nbscx investment picks
  • Holdings: Endologix, Inc., Biomarin Pharmaceutical, Inc., Team Health Holdings Inc, Triumph Group, Inc., Signature Bank
  • Category: Small Growth
  • Morningstar Rating: 2 Stars
Sign-up for nskix investment picks
  • Holdings: Endologix, Inc., Biomarin Pharmaceutical, Inc., Team Health Holdings Inc, Triumph Group, Inc., Signature Bank
  • Category: Small Growth
  • Morningstar Rating: 1 Stars
Sign-up for nskax investment picks
  • Holdings: Endologix, Inc., Biomarin Pharmaceutical, Inc., Team Health Holdings Inc, Triumph Group, Inc., Signature Bank
  • Category: Small Growth
  • Morningstar Rating: 1 Stars
Sign-up for ncscx investment picks
  • Holdings: Endologix, Inc., Biomarin Pharmaceutical, Inc., Team Health Holdings Inc, Triumph Group, Inc., Signature Bank
  • Category: Small Growth
  • Morningstar Rating: 2 Stars
Sign-up for nskax.lw investment picks
  • Holdings: Genesee & Wyoming, Inc. Class A, Endologix, Inc., Financial Engines, Inc., Ixia, Shutterfly, Inc.
  • Category: Small Growth
  • Morningstar Rating: 3 Stars
Sign-up for wfgtx investment picks
  • Holdings: Genesee & Wyoming, Inc. Class A, Endologix, Inc., Financial Engines, Inc., Ixia, Shutterfly, Inc.
  • Category: Small Growth
  • Morningstar Rating: 3 Stars
Sign-up for wfgdx investment picks
  • Holdings: Genesee & Wyoming, Inc. Class A, Endologix, Inc., Financial Engines, Inc., Ixia, Shutterfly, Inc.
  • Category: Small Growth
  • Morningstar Rating: 3 Stars
Sign-up for wemax investment picks
  • Holdings: Genesee & Wyoming, Inc. Class A, Endologix, Inc., Financial Engines, Inc., Ixia, Shutterfly, Inc.
  • Category: Small Growth
  • Morningstar Rating: 3 Stars
Sign-up for wemcx investment picks
  • Holdings: Genesee & Wyoming, Inc. Class A, Endologix, Inc., Financial Engines, Inc., Ixia, Shutterfly, Inc.
  • Category: Small Growth
  • Morningstar Rating: 4 Stars
Sign-up for wemix investment picks
  • Holdings: Genesee & Wyoming, Inc. Class A, Endologix, Inc., Financial Engines, Inc., Ixia, Shutterfly, Inc.
  • Category: Small Growth
  • Morningstar Rating: 3 Stars
Sign-up for wemax.lw investment picks
  • Holdings: Endologix, Inc., Biomarin Pharmaceutical, Inc., Team Health Holdings Inc, Triumph Group, Inc., Signature Bank
  • Category: Small Growth
  • Morningstar Rating: 2 Stars
Sign-up for NSKIX investment picks

 
Stock Quotes for Endologix, Inc. top ^
  • Industry: Medical Instruments & Supplies
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Speculative Growth
Sign-up for elgx investment picks

 
News Articles for Endologix, Inc. top ^
2013/3/11
IRVINE, Calif., March 11, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX) , developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer and Shelley Thunen, Chief Financial Officer, are scheduled to present at the 25th Annual ROTH Conference in Laguna Niguel, CA.
Sign-up for Endologix to Present at the 25th Annual ROTH Conference investment picks
2013/2/27
IRVINE, Calif., Feb.
Sign-up for Endologix Reports 27% and 25% Revenue Growth for the Full Year and Fourth Quarter 2012 investment picks
2013/2/7
IRVINE, Calif., Feb.
Sign-up for Endologix to Report Fourth Quarter and Full Year 2012 Financial Results on February 27, 2013 investment picks
2013/4/8
IRVINE, Calif., April 8, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX) , developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its first quarter 2013 financial results, which will take place on Tuesday, April 30, 2013 after the close of the market.
Sign-up for Endologix to Report First Quarter 2013 Financial Results on April 30, 2013 investment picks
2013/4/16
IRVINE, Calif., April 16, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX) , developer and marketer of innovative treatments for aortic disorders, announced today that it has received U.S. Food and Drug Administration (FDA) approval of its premarket approval (PMA) supplement for a broadened indication for the Company's 21Fr profile and smaller EVAR systems to include totally percutaneous endovascular aneurysm repair (PEVAR) based upon the outcomes of the first prospective, multicenter, randomized clinical trial (The PEVAR Trial). The Endologix EVAR platforms include the Powerlink ® with IntuiTrak® System and the AFX™ Endovascular AAA System, which are the first and only among commercially available endografts to achieve the totally percutaneous labeling expansion facilitated using the Perclose ProGlide ® Suture-Mediated Closure System made by healthcare company Abbott.
Sign-up for Endologix Announces FDA Approval of First Percutaneous Indication for Endovascular Abdominal Aortic Aneurysm Repair investment picks
2013/4/15
IRVINE, Calif., April 15, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX) , developer and marketer of innovative treatments for aortic disorders, announced today that Roderick de Greef will retire from the Board of Directors at the end of his current term, which ends on May 23, 2013, the date of the Company's annual shareholder meeting.
Sign-up for Endologix Board Member Roderick de Greef to Retire; Thomas F. Zenty, III to Stand for Election as Board Member investment picks
2013/4/30
Provides Update on New Product Pipeline Including Enhancements to Ventana Program That Will Delay IDE Enrollment and Limited Market Introduction in Europe IRVINE, Calif., April 30, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX) , developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three months ended March 31, 2013 and provided an update on the company's new product pipeline.
Sign-up for Endologix Reports 22% Revenue Growth for the First Quarter 2013 investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Funds Holding Endologix, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Funds Holding Endo Health Solutions Inc  |  Next: Funds Holding Energen Corp